See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...
A recent study has found that lenacapavir, an injectable medication administered twice a year, is more effective at preventing HIV among gay, bisexual, and transgender people than a daily regimen of ...
LoveBScott on MSN
Who's getting protected? Celebrities you didn’t know were on PrEP
From joining awareness campaigns to posting their personal prevention journeys, celebrities are getting on PrEP. If you don’t ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...
Add Yahoo as a preferred source to see more of our stories on Google. Close up barefoot young gay male couple in pajamas cuddling on bed in morning I haven't taken my pills in two weeks. I went to my ...
Healthvana spokesman Michael Foxworth Blasingame David taffet | Senior staff writerTaffet@DallasVoice.com Overcoming the stigma related to HIV is one of the biggest reasons people use Healthvana for ...
(CNN) — A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP.
Lenacapavir, a twice-yearly injectable antiretroviral, demonstrated 100% effectiveness for preventing HIV acquisition in a large study of young cisgender women in Africa, Gilead Sciences announced ...
Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a game-changer in the fight to end the global HIV epidemic. Looking ahead, once-yearly ...
Since the start of the HIV epidemic in 1981, over 700,000 Americans have lost their lives to AIDS. Being infected used to be a death sentence. But now, 40 years later, the U.S. is on the precipice of ...
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes Zandraetta Tims-Cook, MD, MPH, AAHIVS In the US, we have made remarkable ...
Hosted on MSN
HIV: Monthly PrEP drug candidate shows promise
A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results